Table I.

Characteristics and quality scores of studies^a comparing BMI and IVF outcomes in women receiving donor oocytes.

Study	Year	Location	Design	Inclusion and exclusion criteria	Characteristics of oocyte donors described	COH protocol described	Donor oocyte recipient protocol described	Quality score (out of 19 possible points)	Population BMI (kg/m2)
									<20	20–24.9	25–29.9	≥30
Bellver et al.	2007	Spain	RC	I: Donor oocyte recipients, recent BMI, good embryo quality E: RPL, APA, no uterine pathology or severe sperm pathology	Yes	Yes	Yes	18	471	1613	450	122
Bodri et al.	2010	Spain	RC	I: Donor oocyte recipients, Black, East Asian and Caucasian E: Frozen embryo cycles	Yes	No	Yes	14	195	544	92	67
DeUgarte et al.	2010	CA, USA	RC	I: Donor oocyte recipients E: Smokers, PCOS, RPL, DM, HTN, rescue ICSI	Yes	No	Yes	16	9	125	112	103
Styne-Gross et al.	2005	NJ, USA	RC	I: Donor oocyte recipients E: None specified	Yes	No	Yes	15	101	284	74	77
Wattanakumtornkul et al.	2003	MN, USA	RC	I: Donor oocyte recipients E: No BMI data	Yes	Yes	Yes	15	7	52	25	12
Jungheim	2012	MO, USA	RC	I: Donor oocyte recipients E: None	Yes	Yes	Yes	–	8	47	39	29

RC, retrospective cohort; COH, controlled ovarian hyperstimulation; I, inclusion criteria; E, exclusion criteria; RPL, recurrent pregnancy loss; APA, antiphospholipid antibodies; PCOS, polycystic ovary syndrome; DM, diabetes mellitus; HTN, hypertension; ICSI, intracytoplasmic sperm injection.

^aAs the original search was in 2011, an additional search was performed and no further suitable papers were identified for inclusion.